Centene Corporation (CNC)
NYSE: CNC · IEX Real-Time Price · USD
74.00
-1.68 (-2.22%)
At close: Apr 26, 2024, 4:00 PM
73.00
-1.00 (-1.35%)
After-hours: Apr 26, 2024, 7:59 PM EDT

Centene Revenue

Centene had revenue of $155.52B in the twelve months ending March 31, 2024, with 6.34% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $40.41B with 3.90% year-over-year growth. In the year 2023, Centene had annual revenue of $154.00B with 6.54% growth.

Revenue (ttm)
$155.52B
Revenue Growth
+6.34%
P/S Ratio
0.25
Revenue / Employee
$2,321,149
Employees
67,000
Market Cap
39.58B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023154.00B9.45B6.54%
Dec 31, 2022144.55B18.57B14.74%
Dec 31, 2021125.98B14.87B13.38%
Dec 31, 2020111.12B36.48B48.87%
Dec 31, 201974.64B14.52B24.16%
Dec 31, 201860.12B11.73B24.25%
Dec 31, 201748.38B7.78B19.15%
Dec 31, 201640.61B17.85B78.41%
Dec 31, 201522.76B6.20B37.44%
Dec 31, 201416.56B5.70B52.44%
Dec 31, 201310.86B2.75B33.95%
Dec 31, 20128.11B2.90B55.62%
Dec 31, 20115.21B763.15M17.16%
Dec 31, 20104.45B345.46M8.42%
Dec 31, 20094.10B738.35M21.95%
Dec 31, 20083.36B595.49M21.51%
Dec 31, 20072.77B946.58M51.94%
Dec 31, 20061.82B590.24M47.90%
Dec 31, 20051.23B231.26M23.10%
Dec 31, 20041.00B231.21M30.04%
Dec 31, 2003769.73M308.24M66.79%
Dec 31, 2002461.49M134.92M41.31%
Dec 31, 2001326.57M105.22M47.54%
Dec 31, 2000221.35M19.92M9.89%
Dec 31, 1999201.43M50.99M33.90%
Dec 31, 1998150.44M--
Dec 31, 1997---
Dec 31, 1996---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cencora 271.58B
Humana 109.24B
Takeda Pharmaceutical 29.40B
GE HealthCare Technologies 19.55B
IQVIA Holdings 14.98B
Haleon 14.31B
Alcon 9.46B
Moderna 6.85B
Revenue Rankings